Editor Name: Dr. Shuangli MI
Educational Qualification: Ph.D
Designation: Professor, Principal Investigator at Beijing Institute of Genomics, Chinese Academy of Sciences
Department: Genomic and Precision Medicine
Beijing Institute of Genomics
Research Interest: Epigenetic regulation mechanism of non-coding RNAs in Cancer, Identification of biomarkers for cancer diagnosis or prognosis, Leukemia, Pharmacology, Cancer Genomics.
Biography: Dr. Shuangli Mi is currently working as principal investigator in Beijing Institute of Genomics, Chinese Academy of Sciences. She received her Ph.D. in Peking University, Beijing, China. She got her postdoctoral training in University of Chicago to study the mechanisms for microRNAs regulation in acute leukemia and pharmacogenomics for personalized medicine. She is now focusing on the epigenetic roles of non-coding RNAs including miRNAs and lncRNAs in carcinogenesis and tumor progression and identify novel biomarkers for cancer diagnosis and prognosis.
Organizations and Activities:
2008-2018 Member of the American Society of Hematology (ASH)
2007-2018 Member of the American Association for Cancer Research (AACR)